NVO earnings date and last-quarter result: last quarter beat, P/E 11.33. Updated 2026-07-23.
Novo Nordisk (NVO) Research Hub
Novo Nordisk (NVO) trades on NYSE, DK in the Healthcare (Drug Manufacturers - General) sector. As of 2026-10-26, shares last closed at 39.13 USD (+0.20%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E 11.33, market cap 214.97B. This hub links to the full technical, earnings and options research available for NVO.
Last updated 2026-10-26 · Source: end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Drug Manufacturers - General) |
|---|---|
| Exchange | NYSE, DK |
| Last close | 39.13 USD (+0.20%) |
| 52-week range | 36.85 USD – 52.12 USD |
| Trend regime | Range |
| 14-day RSI | 63.7 (Bullish) |
| Trailing P/E | 11.33 |
| Market cap | 214.97B |
| Dividend yield | 3.76% |
Available research for NVO
Covered Call on NVO: how it works, illustrative setup around the real 39.13 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on NVO: how it works, illustrative setup around the real 39.13 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on NVO: how it works, illustrative setup around the real 39.13 USD price, max profit/loss, breakeven and when to use it. Educational.
NVO technical analysis: range, last 39.13 USD, RSI 63.7, 52w range 36.85 USD–52.12 USD, real support/resistance. Updated 2026-10-26.
More on SniperIQ
Frequently asked questions
What sector is NVO in?
Novo Nordisk (NVO) is classified under Healthcare (Drug Manufacturers - General), listed on NYSE, DK.
Is NVO in an uptrend or downtrend?
As of 2026-10-26, NVO is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is NVO's trailing P/E ratio?
NVO's trailing P/E is 11.33, with a market cap of 214.97B. See the earnings research page for full valuation detail.